CN1127348C - Leukoderma treating medicine - Google Patents
Leukoderma treating medicine Download PDFInfo
- Publication number
- CN1127348C CN1127348C CN 01120476 CN01120476A CN1127348C CN 1127348 C CN1127348 C CN 1127348C CN 01120476 CN01120476 CN 01120476 CN 01120476 A CN01120476 A CN 01120476A CN 1127348 C CN1127348 C CN 1127348C
- Authority
- CN
- China
- Prior art keywords
- medicine
- radix astragali
- flos carthami
- semen cuscutae
- raw material
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The present invention relates to a medicine for treating vitiligo, which comprises parslane herb, safflower, astragalus root, tribulus terrestris, dodder seed, century, psoraleae, etc. Proved by clinical tests, the medicine has conspicuous effect on treating vitiligo.
Description
Invention field
The present invention relates to the leukodermic medicine of a kind of treatment.
Technical background
Vitiligo is a kind of common skin metabolism of pigment obstacle disease.Its cause of disease is comparatively complicated, and is relevant with multiple factors such as autoimmune, endocrine, heredity, metabolism of trace elements imbalances.Doctor trained in Western medicine does not have specific therapy medicine and method.Though it is many to treat leukodermic Chinese medicine, effect waits to improve.
Summary of the invention
The purpose of this invention is to provide the leukodermic medicine for external use of a kind of effective treatment.This medicine is made simple, low production cost, and through clinical trial proof curative effect certainly.
Medicine of the present invention comprises following raw material by weight:
Herba Portulacae 0-100
Flos Carthami 5-25
Radix Astragali 5-25
Fructus Atriplicis Sibiricae 10-40
Semen Cuscutae 5-25
Folium Agaves variegatae 0-100
Fructus Psoraleae 0-25
The method for preparing said medicine comprises said medicine ethanol, preferred 50-99% ethanol, and most preferably 95-99% is alcohol-pickled, the preferred 20-40 of soak time days, best about 30 days, refilters precipitation, encapsulation then.
Certainly, also said medicine can be prepared into any dosage form that is suitable for using clinically, for example use substrate, make externally used paste as vaseline, tallow etc.
According to a preferred embodiment of the invention, medicine of the present invention comprises following raw material by weight:
Herba Portulacae 20-100
Flos Carthami 5-25
Radix Astragali 5-25
Fructus Atriplicis Sibiricae 10-40
Semen Cuscutae 5-25
This scheme mainly is applicable to leukodermic progressive stage.
According to another preferred embodiment of the present invention, medicine of the present invention comprises following raw material by weight:
Flos Carthami 5-25
Radix Astragali 5-25
Fructus Atriplicis Sibiricae 10-40
Semen Cuscutae 5-25
Folium Agaves variegatae 20-100
This programme is suitable for leukodermic stable phase.
According to also preferred embodiment of the present invention, medicine of the present invention comprises following raw material by weight:
Flos Carthami 5-25
Radix Astragali 5-25
Fructus Atriplicis Sibiricae 10-40
Semen Cuscutae 5-25
Fructus Psoraleae 5-25
This programme is applicable to leukodermic acra type.
The using method of medicine of the present invention is directly to apply the affected part.Can choose the middle long wave ultraviolet lamp (seeing another piece patent of the applicant, application number 01220115.4) that irradiation has special shaping device in addition wantonly in application on April 23 calendar year 2001.Facilitate and keep the minimum erythema dose of affected part, the color island can appear in later affected part, and the cotton-shaped colour of skin of cloud is recovered, and until recovery from illness, keeps 2 weeks of treatment again.So generally need 2 months to half a year.
Specific embodiment
Embodiment 1
Herba Portulacae 50g
Flos Carthami 10g
Radix Astragali 10g
Fructus Atriplicis Sibiricae 20g
Semen Cuscutae 10g
Above-mentioned raw materials filtered then, precipitates and encapsulated with 99% alcohol-pickled one month of 200g.
Embodiment 2
Flos Carthami 10g
Radix Astragali 10g
Fructus Atriplicis Sibiricae 20g
Semen Cuscutae 10g
Folium Agaves variegatae 50g
Above-mentioned raw materials filtered then, precipitates and encapsulated with 99% alcohol-pickled one month of 200g.
Embodiment 3
Flos Carthami 20g
Radix Astragali 20g
Fructus Atriplicis Sibiricae 30g
Semen Cuscutae 20g
Fructus Psoraleae 10g
Above-mentioned raw materials filtered then, precipitates and encapsulated with 99% alcohol-pickled one month of 200g.
Clinical trial
The effect judgment criteria:
Cure: white macula disappears, and the colour of skin is restored fully; Effectively: the colour of skin is partly restored.
Embodiment 1 Drug therapy patients with vitiligo 53 examples, several 245 places of skin lesion, effective percentage 100% as a result, cure rate 73%.
Embodiment 2 Drug therapy patients with vitiligo 135 examples, skin lesion 628 places, effective percentage 82%, cure rate 61%.
Embodiment 3 Drug therapy patients with vitiligo 15 examples, skin lesion 127 places, effective percentage 25%, cure rate 7%.
Above result shows that medicine of the present invention is evident in efficacy to vitiligo.
Claims (5)
1, the leukodermic medicine of a kind of treatment is characterized in that its active component is mainly made by following raw material by weight:
Herba Portulacae 0-100
Flos Carthami 5-25
Radix Astragali 5-25
Fructus Atriplicis Sibiricae 10-40
Semen Cuscutae 5-25
Folium Agaves variegatae 0-100
Fructus Psoraleae 0-25.
2, the medicine of the described treatment vitiligo of claim 1 is characterized in that its active component is mainly made by following raw material by weight:
Herba Portulacae 20-100
Flos Carthami 5-25
Radix Astragali 5-25
Fructus Atriplicis Sibiricae 10-40
Semen Cuscutae 5-25.
3, the medicine of the described treatment vitiligo of claim 1 is characterized in that its active component is mainly made by following raw material by weight:
Flos Carthami 5-25
Radix Astragali 5-25
Fructus Atriplicis Sibiricae 10-40
Semen Cuscutae 5-25
Folium Agaves variegatae 20-100.
4, the medicine of the described treatment vitiligo of claim 1 is characterized in that its active component is mainly made by following raw material by weight:
Flos Carthami 5-25
Radix Astragali 5-25
Fructus Atriplicis Sibiricae 10-40
Semen Cuscutae 5-25
Fructus Psoraleae 5-25.
5, the method for preparing any described medicine among the claim 1-4 comprises described medicine with alcohol-pickled, filters precipitation and encapsulation then.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 01120476 CN1127348C (en) | 2001-07-17 | 2001-07-17 | Leukoderma treating medicine |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 01120476 CN1127348C (en) | 2001-07-17 | 2001-07-17 | Leukoderma treating medicine |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1332006A CN1332006A (en) | 2002-01-23 |
| CN1127348C true CN1127348C (en) | 2003-11-12 |
Family
ID=4664163
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 01120476 Expired - Fee Related CN1127348C (en) | 2001-07-17 | 2001-07-17 | Leukoderma treating medicine |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1127348C (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN100350934C (en) * | 2003-07-21 | 2007-11-28 | 马柏林 | Baidianxiao treaditional Chinese medicine for treating vitiligo and preparation method thereof |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101380421B (en) * | 2008-10-22 | 2011-04-27 | 张仲武 | Leukoderma treating medicine |
| CN101496844B (en) * | 2009-03-19 | 2012-06-06 | 董娜 | External preparation for treating leukoderma and method for preparing and using the same |
| CN102526205A (en) * | 2011-12-30 | 2012-07-04 | 张文知 | Leukoderma ointment |
| CN104013725B (en) * | 2014-06-24 | 2015-12-02 | 任兴文 | Be used for the treatment of leukodermic Chinese medicinal formulae |
| CN105055500A (en) * | 2015-07-25 | 2015-11-18 | 东莞邦富实业投资有限公司 | Traditional Chinese medicinal prescription for treating leucoderma as well as preparation method and application method of traditional Chinese medicinal prescription |
-
2001
- 2001-07-17 CN CN 01120476 patent/CN1127348C/en not_active Expired - Fee Related
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN100350934C (en) * | 2003-07-21 | 2007-11-28 | 马柏林 | Baidianxiao treaditional Chinese medicine for treating vitiligo and preparation method thereof |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1332006A (en) | 2002-01-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1879812A (en) | Chinese medicinal composition for increasing egg production rate of layer and method for preparing same | |
| CN1695694A (en) | Chinese traditional medicine for treating breast disease and preparing technique | |
| CN1127348C (en) | Leukoderma treating medicine | |
| CN1879730A (en) | Chinese medicinal composition for preventing and treating baby pig diarrhea, its preparation method and use | |
| CN1895555A (en) | Bone-connecting pill and its preparation | |
| CN1915369A (en) | Pill for treating whitish and turbid urine of women fungal leucorrhea of dedicatedly | |
| CN1823959A (en) | Heart vessel free flowing dispersion tablet and its preparation method | |
| CN1879816A (en) | Chinese medicinal composition for promoting growth of meat chicken and method for preparing same | |
| CN1047530C (en) | Efficient disinfectant for prawn and its preparing process | |
| CN1486736A (en) | Fibrillation-resisting liver softening bolus as compound Chinese medicine prepn for treating fibrillation and cirthosis of liver | |
| CN1054541C (en) | Traditional Chinese medicine for treating mastosis | |
| CN1081924C (en) | Pharmaceutical composition comprising plant worms and muirapuama | |
| CN1246000C (en) | Guangsheng hemp extract, its preparing method and use | |
| CN1212130C (en) | Medicine for treating psoriasis, ichthyosis and eczema | |
| CN1895477A (en) | Antidespressant and its preparation | |
| CN1463192A (en) | Herb compsns. for treating dopy and agrypnia | |
| CN1130216C (en) | Medicine for preventing and treating radiation damage of central nervous system | |
| CN1130218C (en) | Chinese medicine preparation for treating spinal damage and its preparing method | |
| CN1799598A (en) | Chinese medicinal composition for treating spleen and stomach diseases and preparation method thereof | |
| CN1356132A (en) | Chinese-medicinal bag tea for treating chronic pharyngitis and vocal fold disease and its preparing process | |
| CN1186063C (en) | Medicine for treating diabetes and its complication | |
| CN1356117A (en) | Capsule 'Tangniaoshenkang' for treating diabetes | |
| CN1385204A (en) | Antianaphylactic Chinese medicine preparation | |
| CN1311025A (en) | Medicine for curing lupus erythematosus etc. immune diseases induced diseases | |
| CN1210049C (en) | Chinese medicine composition for treating diabetes |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C17 | Cessation of patent right | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20031112 |